565 related articles for article (PubMed ID: 22270990)
1. Prognostic factors for recurrence of papillary thyroid carcinoma in the lymph nodes, lung, and bone: analysis of 5,768 patients with average 10-year follow-up.
Ito Y; Kudo T; Kobayashi K; Miya A; Ichihara K; Miyauchi A
World J Surg; 2012 Jun; 36(6):1274-8. PubMed ID: 22270990
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors of papillary thyroid carcinoma vary according to sex and patient age.
Ito Y; Kudo T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2011 Dec; 35(12):2684-90. PubMed ID: 21953129
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of extranodal extension of regional lymph node metastasis in papillary thyroid cancer.
Wu MH; Shen WT; Gosnell J; Duh QY
Head Neck; 2015 Sep; 37(9):1336-43. PubMed ID: 24821456
[TBL] [Abstract][Full Text] [Related]
4. Lymph node recurrence in patients with N1b papillary thyroid carcinoma who underwent unilateral therapeutic modified radical neck dissection.
Ito Y; Kudo T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2012 Mar; 36(3):593-7. PubMed ID: 22207493
[TBL] [Abstract][Full Text] [Related]
5. Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.
Liu FH; Kuo SF; Hsueh C; Chao TC; Lin JD
J Surg Oncol; 2015 Aug; 112(2):149-54. PubMed ID: 26175314
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size.
Ito Y; Fukushima M; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(6):457-64. PubMed ID: 22447137
[TBL] [Abstract][Full Text] [Related]
7. Excellent Prognosis of Central Lymph Node Recurrence-Free Survival for cN0M0 Papillary Thyroid Carcinoma Patients Who Underwent Routine Prophylactic Central Node Dissection.
Ito Y; Miyauchi A; Masuoka H; Fukushima M; Kihara M; Miya A
World J Surg; 2018 Aug; 42(8):2462-2468. PubMed ID: 29372373
[TBL] [Abstract][Full Text] [Related]
8. Comparison of Lobectomy vs Total Thyroidectomy for Intermediate-Risk Papillary Thyroid Carcinoma With Lymph Node Metastasis.
Xu S; Huang H; Huang Y; Qian J; Wang X; Xu Z; Liu S; Liu J
JAMA Surg; 2023 Jan; 158(1):73-79. PubMed ID: 36449303
[TBL] [Abstract][Full Text] [Related]
9. Occult lymph node metastasis and risk of regional recurrence in papillary thyroid cancer after bilateral prophylactic central neck dissection: A multi-institutional study.
Lee YC; Na SY; Park GC; Han JH; Kim SW; Eun YG
Surgery; 2017 Feb; 161(2):465-471. PubMed ID: 27574773
[TBL] [Abstract][Full Text] [Related]
10. Prognosis and prognostic factors of papillary thyroid carcinoma in patients under 20 years.
Ito Y; Kihara M; Takamura Y; Kobayashi K; Miya A; Hirokawa M; Miyauchi A
Endocr J; 2012; 59(7):539-45. PubMed ID: 22472193
[TBL] [Abstract][Full Text] [Related]
11. Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.
Pedrazzini L; Baroli A; Marzoli L; Guglielmi R; Papini E
Minerva Endocrinol; 2013 Sep; 38(3):269-79. PubMed ID: 24126547
[TBL] [Abstract][Full Text] [Related]
12. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
13. Prognosis of patients with papillary thyroid carcinoma showing postoperative recurrence to the central neck.
Ito Y; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
World J Surg; 2011 Apr; 35(4):767-72. PubMed ID: 21181469
[TBL] [Abstract][Full Text] [Related]
14. Predictors of recurrence after total thyroidectomy plus neck dissection and radioactive iodine ablation for high-risk papillary thyroid carcinoma.
Kim Y; Roh JL; Song D; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2020 Oct; 122(5):906-913. PubMed ID: 32588461
[TBL] [Abstract][Full Text] [Related]
15. Significance of prophylactic modified radical neck dissection for patients with low-risk papillary thyroid carcinoma measuring 1.1-3.0 cm: first report of a trial at Kuma Hospital.
Ito Y; Tsushima Y; Masuoka H; Yabuta T; Fukushima M; Inoue H; Tomoda C; Kihara M; Higashiyama T; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Surg Today; 2011 Nov; 41(11):1486-91. PubMed ID: 21969150
[TBL] [Abstract][Full Text] [Related]
16. Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma.
Baek SK; Jung KY; Kang SM; Kwon SY; Woo JS; Cho SH; Chung EJ
Thyroid; 2010 Feb; 20(2):147-52. PubMed ID: 19785522
[TBL] [Abstract][Full Text] [Related]
17. Not the number but the location of lymph nodes matters for recurrence rate and disease-free survival in patients with differentiated thyroid cancer.
de Meer SG; Dauwan M; de Keizer B; Valk GD; Borel Rinkes IH; Vriens MR
World J Surg; 2012 Jun; 36(6):1262-7. PubMed ID: 22270993
[TBL] [Abstract][Full Text] [Related]
18. Case report: exceptionally rapid growth character of hobnail variant of papillary thyroid carcinoma: a report of four cases.
Ito Y; Hirokawa M; Hayashi T; Ota H; Oshita M; Kihara M; Miya A; Miyauchi A
Endocr J; 2020 Oct; 67(10):1047-1053. PubMed ID: 32554948
[TBL] [Abstract][Full Text] [Related]
19. Extranodal extension of lymph node metastasis as a prognostic indicator of recurrence and survival in papillary thyroid carcinoma.
Roh JL; Park JW; Jeong J; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2017 Sep; 116(4):450-458. PubMed ID: 28608492
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of low-risk papillary thyroid carcinoma patients: its relationship with the size of primary tumors.
Ito Y; Kudo T; Kihara M; Takamura Y; Kobayashi K; Miya A; Miyauchi A
Endocr J; 2012; 59(2):119-25. PubMed ID: 22068114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]